Researcher
Isabelle Vanden Bempt
- Disciplines:Clinical genetics and molecular diagnostics, Medical genomics, Medical transcriptomics
Affiliations
- Laboratory for Genetics of Malignant Disorders (Division)
Member
From24 Nov 2021 → Today - Department of Human Genetics (Department)
Member
From1 Oct 2018 → 13 Dec 2021 - Translational Cell & Tissue Research (Division)
Member
From15 Aug 2003 → 30 Sep 2008
Projects
1 - 2 of 2
- Whole-genome optical mapping for comprehensive analysis of sarcoma genomes in a diagnostic settingFrom13 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a better selection of systemic treatment for patients with ER-positive HER2-negative breast cancer: the use of prognostic and predictive markers in early and metastatic settingFrom1 May 2017 → 14 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 42
- Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.(2022)
Authors: Sofie Claerhout, Lien Spans, Christophe Dooms, Els Wauters, Johan Vansteenkiste, Birgit Weynand, Isabelle Vanden Bempt
Pages: 242 - 249 - Case Report: An Unusual Course of Angiosarcoma After Lung Transplantation(2022)
Authors: Lucienne Michaux, Isabelle Vanden Bempt, Sascha Vermeer, Patrick Schöffski, Birgit Weynand, Raphael Sciot, Laurens Ceulemans, Geert Verleden, Dirk Van Raemdonck, Lieven Dupont, et al.
Number of pages: 7 - THE SINGLE-CELL PATHOLOGY LANDSCAPE OF PEDIATRIC GLIOMA(2021)
Authors: Julie Messiaen, Yannick Van Herck, Francesca Maria Bosisio, Steven De Vleeschouwer, Philippe De Vloo, Bart Depreitere, Isabelle Vanden Bempt, Raphael Sciot, Frederik De Smet
Pages: 119 - 119Number of pages: 1 - Towards a better selection of systemic treatment for patients with ER-positive HER2-negative breast cancer: the use of prognostic and predictive markers in early and metastatic setting(2021)
Authors: Laurence Slembrouck, Patrick Neven, Isabelle Vanden Bempt, Giuseppe Floris
- The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis(2021)
Authors: Isabelle Vanden Bempt
Pages: 429 - 441Number of pages: 13 - Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study(2021)
Authors: Lien Spans, Hilde Brems, Annouschka Laenen, Ignace Vergote, Toon Van Gorp, Els Van Nieuwenhuysen, Sileny Han, Anne-Sophie Van Rompuy, Isabelle Vanden Bempt
Pages: 694 - 701Number of pages: 8 - Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma(2021)
Authors: Michael Dewaele, Panagiotis Karras, Joanna Poźniak, Nina Van Raemdonck, Jonas Demeulemeester, Francesca Maria Bosisio, Joost van den Oord, Isabelle Vanden Bempt, Diether Lambrechts, Thierry Voet, et al.
Pages: 1135 - +Number of pages: 23 - Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies(2021)
Authors: Liesbeth Lenaerts, Charlotte Maggen, Huiwen Che, Peter Vandenberghe, Daan Dierickx, Lucienne Michaux, Barbara Dewaele, Patrick Neven, Giuseppe Floris, Thomas Tousseyn, et al.
Number of pages: 12 - Curative, Organ-Sparing, Multimodal, Perioperative Treatment of a Young Patient with a Rectoanal Inflammatory Myofibroblastic Tumor(2021)
Authors: Patrick Schöffski, Isabelle Vanden Bempt, Vincent Vandecaveye, Raphael Sciot, Gert De Hertogh, Albert Wolthuis
Pages: 269 - 275Number of pages: 7 - Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2-early breast cancer(2021)
Authors: Laurence Slembrouck, Isabelle Vanden Bempt, Hans Wildiers, Ann Smeets, Anne-Sophie Van Rompuy, Chantal Van Ongeval, Caroline Weltens, Kevin Punie, Els Van Nieuwenhuysen, Sileny Han, et al.
Pages: 1297 - 1309Number of pages: 13